v3.19.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Operating expenses:        
Research and development $ 53,538 $ 43,355 $ 154,457 $ 105,202
General and administrative 19,018 16,865 61,525 50,093
Total operating expenses 72,556 60,220 215,982 155,295
Loss from operations (72,556) (60,220) (215,982) (155,295)
Interest and other income, net 661 1,859 3,502 4,611
Loss before provision for income taxes (71,895) (58,361) (212,480) (150,684)
Provision for income taxes 0 0 0 3
Net loss (71,895) (58,361) (212,480) (150,687)
Other comprehensive loss:        
Unrealized gain (loss) on available-for-sale securities 60 56 573 (298)
Comprehensive loss $ (71,835) $ (58,305) $ (211,907) $ (150,985)
Net loss per common share:        
Basic and diluted net loss per common share $ (1.31) $ (1.29) $ (4.32) $ (3.49)
Weighted-average shares outstanding used to calculate basic and diluted net loss per common share 54,920 45,406 49,176 43,148

Source